Explore our industry-leading range of highly pure nutritional ingredients, botanical extracts, and functional substrates customized for worldwide healthcare markets.
Understanding market dynamics, segment growth, and structural demands driving the international wellness economy.
The global prebiotic ingredients market size was valued at over USD 6.5 Billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) exceeding 8.2% from 2024 to 2032. Rapidly increasing awareness regarding gut microbiome wellness, expanding applications in infant formula, and the replacement of dietary sugars with functional soluble fibers are key drivers.
Fructo-oligosaccharides (FOS), Inulin, and Galacto-oligosaccharides (GOS) dominate the market share. However, next-generation substrates such as Xylo-oligosaccharides (XOS) and Isomalto-oligosaccharides (IMO) are exhibiting the highest growth velocities due to their superior thermal stability and lower effective dosage parameters in clinical trials.
Regulatory frameworks by EFSA and FDA are pivoting towards strict validation of functional claims. Manufacturers require partners who can supply comprehensive clinical data, heavy metal profiles, pesticide residue limits, and non-GMO verifications to satisfy demanding regional compliance agencies.
Shanxi Kawsana Health Co., Ltd. is a professional manufacturer and global supplier of natural botanical extracts, herbal ingredients, and functional health products. With more than 10 years of industry experience, we are committed to providing high-quality plant-based ingredients and comprehensive OEM/ODM solutions for customers worldwide.
Our strategic manufacturing base, situated in Shanxi Province, China, utilizes state-of-the-art technological architectures. We leverage optimized pathways for extraction, column chromatography isolation, multi-stage concentration, and low-temperature spray drying. Operating within a GMP-compliant plant spanning over 12,000 square meters, we run production round-the-clock while upholding structural ecological safeguards.
To support advanced formulation architectures, our facility features a specialized 600-square-meter R&D and Quality Control Center. Our team of biologists, organic chemists, and quality engineers meticulously analyzes raw materials and finished products, verifying identity, purity, and prebiotic efficacy indices.
Beyond raw material supply, Shanxi Kawsana Health Co., Ltd. provides customized end-to-end B2B services. We assist brand developers, supplement marketers, and corporate procurers in navigating the entire product lifecycle from concept to commercialization:
By controlling the process from botanical cultivation sourcing to analytical validation, we eliminate supply chain bottlenecks and guarantee consistent batch-to-batch stability for critical industries.
Inside Shanxi Kawsana Health’s modern manufacturing facility, where every process is standardized to meet rigorous international requirements.
How our customized prebiotic substrates solve formulation challenges across global consumer product sectors.
Challenge: Maintaining prebiotic stability in low pH conditions and avoiding sediment formation over shelf life.
Solution: We supply ultra-filtered, highly soluble prebiotic fibers with minimal viscosity. Our ingredients resist thermal degradation up to 140°C, making them ideal for HTST pasteurized functional juices, sodas, and dairy-free milk formulations.
Challenge: Optimizing synergistic survival rates between probiotic strains and prebiotic growth promoters in capsule formats.
Solution: Developing targeted molecular size distributions of fructans and oligosaccharides that selectively feed specific beneficial gut microflora, such as *Bifidobacterium longum* and *Lactobacillus acidophilus*, while suppressing pathogenic lines.
Challenge: Replacing simple carbohydrates in baking or dairy without losing essential mouthfeel and humectancy.
Solution: Utilizing our specialized long-chain inulin and isomaltulose products to replicate the texturizing properties of fats and sugars while reducing glycemic indices, enhancing fiber claims, and sustaining gut transit comfort.
Driving next-generation microbiome nutrition through biotechnology research, enzyme customization, and clinical verification.
Developing hyper-targeted oligosaccharide profiles through custom enzymatic transglycosylation. Isolating precise degrees of polymerization (DP) to minimize intestinal gas while maximizing selective bifidogenic fermentation rates.
Implementing lipid and protein-based coating matrices to protect vulnerable bioactive additions against stomach acid and high temperature extrusion in pet foods and fortified breakfast cereals.
Utilizing computational biology platforms to simulate gut microbiota interactions with botanical fibers. Aligning customized manufacturing outputs with specific metabolic pathways (e.g., maximizing butyrate synthesis).
Addressing essential queries regarding compliance, chemistry, customization, and global distribution logistics.
High-potency colorants, natural functional components, and industrial processing technologies for advanced manufacturers.
Kawsana Health
